Clarest Pulse

A clinical and regulatory update from Clarest Health’s LTC Pharmacy Division.

2026 Volume 1

CMS is sharpening its focus on antipsychotic use in long-term care, and the implications for your facility go beyond compliance. This volume examines what the new measure means for your team. This edition of the Clarest Pulse also offers ways to maximize the value of your consultant pharmacist, discusses why medication adherence breaks down for seniors at home, and shares details of our new offering, Clarest at Home.

Talk to an expert today!

Perspectives, Articles, and Insights!

Adherence Requires a Human in the Loop: The Limits of Tech-Only Platforms

The $200 Million Question: Why Federal Incentives Can’t Buy More Time for Nurses

The OIG Schizophrenia Audit: Compliance Risks in 2026

The New Old: A Generation that is Redefining Aging

Adherence Requires a Human in the Loop: The Limits of Tech-Only Platforms

The $200 Million Question: Why Federal Incentives Can’t Buy More Time for Nurses

The OIG Schizophrenia Audit: Compliance Risks in 2026